Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115592) titled 'CyberKnife Treatment for Oligorecurrent Lesions After Radical Prostatectomy for Prostate Cancer Guided by PSMA-PET' on Dec. 29, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Army Medical Center of PLA
Condition:
Prostate Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: CyberKnife treatment group guided by PSMA-PET:24;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301515
Published by HT Digital Content Services with permission from Health Daily Digest....